Allogene Therapeutics, Inc.ALLONASDAQ
Loading
Cost of Revenue Over TimeStrong
Percentile Rank100
3Y CAGR+37.7%
5Y CAGR+26.5%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+37.7%/yr
Annual compound
5Y CAGR
+26.5%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
3.2x
Strong expansion
Streak
1 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $37.32M | - |
| 2024 | $0.00 | - |
| 2023 | $0.00 | -100.0% |
| 2022 | $14.29M | - |
| 2021 | $0.00 | -100.0% |
| 2020 | $11.54M | +129.6% |
| 2019 | $5.03M | - |
| 2018 | $0.00 | - |
| 2017 | $0.00 | - |